# Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B

> **NCT00531167** · PHASE4 · COMPLETED · sponsor: **Korea University** · enrollment: 219 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** combination of lamivudine+adefovir vs entecavir

## Key facts

- **NCT ID:** NCT00531167
- **Lead sponsor:** Korea University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2011-04
- **Final completion:** 2012-10
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2012-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00531167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00531167, "Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00531167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*